pDMJ2_SARS2_S_A.23_Q613
(Plasmid
#256989)
-
PurposeExpresses SARS-CoV-2 spike (A.23 Q613) protein for creating pseudotyped virus
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 256989 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepDMJ2
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameSARS-CoV-2 Spike
-
SpeciesSARS-CoV-2
-
MutationF157L, V367F
-
Entrez GeneS (a.k.a. GU280_gp02, spike glycoprotein)
Cloning Information
- Cloning method Gene Synthesis
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2023.03.30.535005 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pDMJ2_SARS2_S_A.23_Q613 was a gift from Jeremy Luban (Addgene plasmid # 256989 ; http://n2t.net/addgene:256989 ; RRID:Addgene_256989) -
For your References section:
S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness. Yurkovetskiy L, Egri S, Kurhade C, Diaz-Salinas MA, Jaimes JA, Nyalile T, Xie X, Choudhary MC, Dauphin A, Li JZ, Munro JB, Shi PY, Shen K, Luban J. bioRxiv [Preprint]. 2023 Apr 24:2023.03.30.535005. doi: 10.1101/2023.03.30.535005. 10.1101/2023.03.30.535005 PubMed 37034621